To evaluate the visual acuity and quality-related satisfaction of patients implanted with a refractive design multifocal intraocular lens (IOL), and evaluate the factors predicting it including angle ...

To evaluate the postoperative outcomes of cataract eyes complicated with coexisting ocular pathologies that underwent implantation of a refractive multifocal intraocular lens (MIOL) with a ...

After bilateral cataract surgery, patients implanted with multifocal intraocular lenses (IOLs) were more likely to be spectacle-independent but also to undergo IOL exchange than those with monofocal ...

Corneal refractive surgery has been performed on millions of patients to decrease their spectacle dependence. Most of these patients have high expectations of visual function—but as these patients age ...

Please provide your email address to receive an email when new articles are posted on . Significantly more patients with multifocal IOLs were spectacle-free for near ...

Angles of the eye have, of late, received a renewed interest secondary to the significant role they play in refractive surgery. Angle kappa is the angle between the visual axis and the pupillary axis ...

Multifocal lenses use multiple refractive zones built in rings to give patients distance and near vision. These lenses are designed to address the problem of presbyopia, in which people over the age ...

A cataract is the opacification of the eye's natural lens, usually causing gradual eyesight deterioration and potentially leading to blindness. Current treatment involves replacing the opacified lens ...

Cataract surgery is a once-in-a-lifetime investment in your eyes that can improve your quality of life for the long term. Advanced lens options can reduce or eliminate the need for glasses after your ...

Two new intraocular lenses (IOLs) that restore vision to people with cataracts are now available in the United States. The new TECNIS ® Multifocal IOLs, developed by Abbott (NYSE: ABT), provide people ...

“As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D—even with our leading products like PanOptix,” said Rob ...